The American Society of Hematology has added 5 more recommendations to it's Choosing Wisely list, which was published in the journal Blood,
Developed as part of Choosing Wisely®, an initiative of the ABIM Foundation, the ASH Choosing Wisely list provides 10 evidence-based recommendations in an effort to prompt conversations between patients and physicians about the necessity and potential harm of certain practices. The first five recommendations were released in 2013 and highlighted in a manuscript published in Blood after months of careful data analysis and review, as well as input from the Society's membership, using the most current evidence about management and treatment options. The list was recently updated to include five additional commonly used tests, treatments, and procedures in hematology that physicians and patients should question in certain circumstances. These new practices to question are highlighted in a new manuscript published in Blood in December 2014, which further describes the methods in development of the list and the evidentiary basis of the recommendations.
Link to the news on the ASH website: http://bit.ly/1I4EX5h
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen